Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?"
- PMID: 34224780
- DOI: 10.1016/j.jhep.2021.06.026
Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?"
Conflict of interest statement
Conflict of interest The authors have no conflict of interest pertinent to this study. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis.J Hepatol. 2020 Oct;73(4):829-841. doi: 10.1016/j.jhep.2020.03.048. Epub 2020 Apr 13. J Hepatol. 2020. PMID: 32298768
-
Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?J Hepatol. 2021 Oct;75(4):992-993. doi: 10.1016/j.jhep.2021.04.025. Epub 2021 Apr 28. J Hepatol. 2021. PMID: 33932487 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical